Frank Ong,
Executive Director, Medical Affairs and Clinical Development
Dr. Ong is currently the Executive Director, Medical Affairs and Clinical Development at NANTHEALTH. Previously, he was Senior Director, Medical and Scientific Affairs of Global MDx at QIAGEN and Associate Director of Medical Affairs at Illumina. He was the Medical Lead for the for the first FDA 510(k)-cleared NGS platform and NGS-based assays submissions and the Global Lead for Medical Education and Communications. Prior to Illumina, Dr. Ong was a Principal Investigator in the Department of Biomedical Sciences at Cedars-Sinai Medical Center where was funded by the National Institutes of Health (NIH) and by the medical center for clinical research on the genetics of blood pressure regulation. Dr. Ong received his Medical Doctorate (M.D.) with honors from the Keck School of Medicine at the University of Southern California, served as Resident Physician in the Department of Family Medicine at Geffen School of Medicine at UCLA, and completed a clinical fellowship in Clinical Molecular Genetics in the Department of Pathology and Laboratory Medicine of UCLA as well as a research fellowship in the Division of Experimental Pathology at Cedars-Sinai Medical Center.
|
|
|
